TY Howton
Fortuna: 1 M $ al 30/06/2026
Fortuna: 1 M $ al 30/06/2026
David Tyronne Howton is Director at Biogene Therapeutics, Inc. since 2026.
Mr. Howton is Chief Operating Officer & Secretary at Solid Biosciences, Inc. since 2023.
Former roles include Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc. in 2012, Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc. from 2013 to 2020, and Chief Operating Officer & General Counsel at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Yale University and graduate studies at Northwestern University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SOLID BIOSCIENCES INC. 0,11 % | 31/03/2026 | 105.077 ( 0,11 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director de Operaciones | 01/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Director de Operaciones | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | Consejero General | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Consejero General | 12/06/2012 |
Make-A-Wish Foundation of Massachusetts | Director/Miembro de la Junta | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of Massachusetts | |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.